CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

BACKGROUND: Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown to improve outcome, including perioperative chemotherapy, postoperative chemoradiotherapy and postoperative chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Slagter, Astrid E., Jansen, Edwin P. M., van Laarhoven, Hanneke W. M., van Sandick, Johanna W., van Grieken, Nicole C. T., Sikorska, Karolina, Cats, Annemieke, Muller-Timmermans, Pietje, Hulshof, Maarten C. C. M., Boot, Henk, Los, Maartje, Beerepoot, Laurens V., Peters, Frank P. J., Hospers, Geke A. P., van Etten, Boudewijn, Hartgrink, Henk H., van Berge Henegouwen, Mark I., Nieuwenhuijzen, Grard A. P., van Hillegersberg, Richard, van der Peet, Donald L., Grabsch, Heike I., Verheij, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131797/
https://www.ncbi.nlm.nih.gov/pubmed/30200910
http://dx.doi.org/10.1186/s12885-018-4770-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131797/
https://www.ncbi.nlm.nih.gov/pubmed/30200910
http://dx.doi.org/10.1186/s12885-018-4770-2

Ejemplares similares